Purpose The aim of this study was to explore the safety and efficacy of bivalirudin in elderly
patients undergoing percutaneous coronary intervention (PCI). Methods An electronic …

Objective To assess the effectiveness and safety of bivalirudin compared with heparin
monotherapy in elderly patients undergoing percutaneous coronary intervention (PCI) …

Objectives: This study aimed to analyze the impact of replacing heparin with bivalirudin in
octogenarians undergoing percutaneous coronary intervention (PCI) on postprocedure …

Background Since older age is a strong predictor of not only bleeding but also of ischemic
events, understanding the risk: benefit profile of bivalirudin in the elderly undergoing primary …

Objective ST-segment elevation myocardial infarction (STEMI) is the most serious type of
acute coronary syndrome. This study aimed to investigate the efficacy and safety of …

Background: This meta-analysis is to evaluate the efficacy and safety of bivalirudin in
patients with ST-elevation myocardial infarction (STEMI). Methods: PubMed, Cochrane …

Objectives We aimed to perform a gender‐based meta‐analysis of the outcome of
bivalirudin versus heparin in patients undergoing percutaneous coronary interventions …

Background The anticoagulant of choice during percutaneous coronary intervention (PCI) in
women is not well established. Methods An electronic search was conducted for trials that …

Bivalirudin has gained ground against unfractionated heparin (UFH) in percutaneous
coronary interventions (PCI), due to a reported better safety profile. However, whether …

Background The efficacy and safety of bivalirudin versus heparin in patients undergoing
percutaneous coronary intervention (PCI) 1 remains controversial in to date. Our meta …